| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Companies Reporting Before The Bell • Addex Therapeutics (NASDAQ:ADXN) is estimated to report earnings for its fourth quarter.
Cautious optimism hangs in the air on Thursday morning as index futures traded up moderately in early hours.
Comerica (NYSE:CMA) reported quarterly earnings of $1.29 per share which beat the analyst consensus estimate of $1.12 by 15.18 ...
Deutsche Bank analyst Bernard von-Gizycki initiates coverage on Comerica (NYSE:CMA) with a Hold rating and announces Price T...
RBC Capital analyst Jon Arfstrom maintains Comerica (NYSE:CMA) with a Outperform and lowers the price target from $63 to $61.
Jefferies analyst Ken Usdin maintains Comerica (NYSE:CMA) with a Buy and lowers the price target from $65 to $60.
UBS analyst Erika Najarian downgrades Comerica (NYSE:CMA) from Buy to Neutral and lowers the price target from $66 to $59.
Truist Securities analyst Brandon King maintains Comerica (NYSE:CMA) with a Buy and raises the price target from $60 to $62.
